Document is current

Article History

Accepted: 8 August 2024

First Online: 16 September 2024

Declarations

:

: Burcu Zeydan receives funding from National Institutes of Health (U54 AG044170 and K12 AR084222).

: Burcu Zeydan is the recipient of the Mayo Clinic Eugene and Marcia Applebaum Award and the Radiology Research Award. Mikael Cohen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Merck, Sanofi, Roche, Celgene-BMS, Janssen, Alexion, Horizon Therapeutics, and Ad Scientiam. Eric Thouvenot received consulting and lecturing fees and travel grants or unconditional research support from the following pharmaceutical companies: Actelion, Biogen, BMS, Merck, Novartis, Roche, and Teva pharma. The rest of the authors did not report disclosures.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Burcu Zeydan: concept and planning of the work described; acquisition, analysis and interpretation of the data; drafting and/or critical revision of the manuscript; and approved the final submitted version of the manuscript. Christine Lebrun-Frenay and Orhun H. Kantarci: concept and planning of the work described; interpretation of the data; critical revision of the manuscript; and approved the final submitted version of the manuscript. Eric Thouvenot: interpretation of the data; critical revision of the manuscript; and approved the final submitted version of the manuscript. Mikael Cohen, Christina J. Azevedo, Naila Makhani, Melih Tutuncu, Aksel Siva, and Darin T. Okuda: critical revision of the manuscript and approved the final submitted version of the manuscript.